America Great Health (AAGH)
0.0029
0.00 (0.00%)
USD |
OTCM |
Jun 20, 16:00
America Great Health Enterprise Value: 63.16M for June 18, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 18, 2024 | 63.16M |
| June 17, 2024 | 63.16M |
| June 14, 2024 | 56.80M |
| June 13, 2024 | 63.16M |
| June 12, 2024 | 63.16M |
| June 11, 2024 | 61.04M |
| June 10, 2024 | 56.80M |
| June 07, 2024 | 56.80M |
| June 06, 2024 | 56.80M |
| June 05, 2024 | 56.80M |
| June 04, 2024 | 56.80M |
| June 03, 2024 | 3.826M |
| May 31, 2024 | 3.826M |
| May 30, 2024 | 22.90M |
| May 29, 2024 | 22.90M |
| May 28, 2024 | 22.90M |
| May 24, 2024 | 22.90M |
| May 23, 2024 | 22.90M |
| May 22, 2024 | 22.90M |
| May 21, 2024 | 22.90M |
| May 20, 2024 | 54.68M |
| May 17, 2024 | 54.68M |
| May 16, 2024 | 54.68M |
| May 15, 2024 | 50.44M |
| May 14, 2024 | 37.73M |
| Date | Value |
|---|---|
| May 13, 2024 | 31.37M |
| May 10, 2024 | 31.37M |
| May 09, 2024 | 29.25M |
| May 08, 2024 | 29.25M |
| May 07, 2024 | 27.13M |
| May 06, 2024 | 30.31M |
| May 03, 2024 | 12.30M |
| May 02, 2024 | 12.30M |
| May 01, 2024 | 14.42M |
| April 30, 2024 | 14.42M |
| April 29, 2024 | 15.69M |
| April 26, 2024 | 19.29M |
| April 25, 2024 | 18.87M |
| April 24, 2024 | 19.08M |
| April 23, 2024 | 21.63M |
| April 22, 2024 | 23.32M |
| April 19, 2024 | 22.90M |
| April 18, 2024 | 21.20M |
| April 17, 2024 | 20.78M |
| April 16, 2024 | 23.53M |
| April 15, 2024 | 29.25M |
| April 12, 2024 | 37.73M |
| April 11, 2024 | 35.61M |
| April 10, 2024 | 42.60M |
| April 09, 2024 | 44.09M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
3.826M
Minimum
May 31 2024
12.14B
Maximum
Jan 27 2021
864.35M
Average
233.20M
Median
Feb 16 2023
Enterprise Value Benchmarks
| CEL-SCI Corp | 54.81M |
| AIM ImmunoTech Inc | 12.69M |
| IGC Pharma Inc | 24.32M |
| NovaBay Pharmaceuticals Inc | 3.155M |
| Protalix BioTherapeutics Inc | 55.51M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.2266M |
| Revenue (Quarterly) | 0.094M |
| Total Expenses (Quarterly) | 0.2283M |
| Gross Profit Margin (Quarterly) | 87.32% |
| Profit Margin (Quarterly) | -240.9% |
| Earnings Yield | -1.41% |
| Normalized Earnings Yield | -1.414 |